Literature DB >> 34606875

The potential of Senolytics in transplantation.

Tomohisa Matsunaga1, Jasper Iske2, Andreas Schroeter3, Haruhito Azuma4, Hao Zhou5, Stefan G Tullius6.   

Abstract

Older organs provide a substantial unrealized potential with the capacity to close the gap between demand and supply in organ transplantation. The potential of senolytics in improving age-related conditions has been shown in various experimental studies and early clinical trials. Those encouraging data may also be of relevance for transplantation. As age-differences between donor and recipients are not uncommon, aging may be accelerated in recipients when transplanting older organs; young organs may, at least in theory, have the potential to 'rejuvenate' old recipients. Here, we review the relevance of senescent cells and the effects of senolytics on organ quality, alloimmune responses and outcomes in solid organ transplantation. This article is part of the Special Issue - Senolytics - Edited by Joao Passos and Diana Jurk.
Copyright © 2021. Published by Elsevier B.V.

Entities:  

Keywords:  Aging; Immunosenescence; Old donors; SASP; Senescent cells; Senolytics; Transplantation

Mesh:

Substances:

Year:  2021        PMID: 34606875     DOI: 10.1016/j.mad.2021.111582

Source DB:  PubMed          Journal:  Mech Ageing Dev        ISSN: 0047-6374            Impact factor:   5.432


  3 in total

Review 1.  Preserving and rejuvenating old organs for transplantation: novel treatments including the potential of senolytics.

Authors:  Tomohisa Matsunaga; Maximilian J Roesel; Andreas Schroeter; Yao Xiao; Hao Zhou; Stefan G Tullius
Journal:  Curr Opin Organ Transplant       Date:  2022-08-09       Impact factor: 2.269

2.  Senolytic drugs: Beyond the promise and the hype.

Authors:  Diana Jurk; João F Passos
Journal:  Mech Ageing Dev       Date:  2022-01-12       Impact factor: 5.498

Review 3.  Targeting cellular senescence to combat cancer and ageing.

Authors:  Chen Wang; Xue Hao; Rugang Zhang
Journal:  Mol Oncol       Date:  2022-06-20       Impact factor: 7.449

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.